facebook
Subscribe50$/product give away!


Submit an Article to Pharmacy HQ     
Please include the author's name, title, and citations.     

ALTACAINE- tetracaine hydrochloride solution


  1. No Title 1572547422
  2. No Title 1572449216
  3. Description:
  4. Clinical Pharmacology:
  5. Indications And Usage:
  6. Contraindications:
  7. Warnings:
  8. Precautions:
  9. Adverse Reactions:
  10. Dosage And Administration:
  11. How Supplied:
  12. Storage:
  13. Principal Display Panel

No Title 1572547422 

Tetracaine Hydrochloride Ophthalmic

Solution, USP 0.5% Sterile

Rx Only

No Title 1572449216 

Tetracaine Hydrochloride Ophthalmic

Solution, USP 0.5% Sterile

Rx Only

Description: 

Tetracaine Hydrochloride 0.5% is a sterile topical ophthalmic solution useful in producing surface anesthesia of the eye. The active ingredient is represented by the structural formula:

 The structural formula for Tetracaine Hydrochloride 0.5% is a sterile topical ophthalmic solution useful in producing surface anesthesia of the eye.

Established name:

Tetracaine Hydrochloride

Chemical name:

Benzoic acid, 4-(butylamino)-,2-(dimethylamino)ethyl ester, monohydrochloride

CONTAINS:

Active: Tetracaine Hydrochloride 0.5%; Preservative: Chlorobutanol; Inactive: Boric Acid, Edetate Disodium, Potassium Chloride, Water for Injection, USP. Hydrochloric Acid and/or Sodium Hydroxide may be added to adjust pH.

Clinical Pharmacology: 

Tetracaine Hydrochloride Ophthalmic Solution, USP 0.5% acts by decreasing the permeability of the neuronal membrane, thereby decreasing the flux of sodium, potassium and other ions associated with propagation of the nerve impulse. The onset of anesthesia usually begins within 30 seconds and lasts a relatively short period of time.

Indications And Usage: 

For procedures in which a rapid and short acting topical ophthalmic anesthetic is indicated such as in tonometry, gonioscopy, removal of corneal foreign bodies, conjunctival scraping for diagnostic purposes, suture removal from the cornea or conjunctiva, other short corneal and conjunctival procedures.

Contraindications: 

Should not be used by the patient without physician supervision, or in those persons showing hypersensitivity to any component of this preparation.

Warnings: 

For topical ophthalmic use only. Not for parenteral use. Not for injection. Do not use solution if it contains crystals or if it is cloudy or discolored. Prolonged use results in diminished duration of anesthesia and retarded healing. This may cause the drug to be used more frequently, creating a vicious circle . Subsequent corneal infection and/or corneal opacification with accompanying permanent visual loss or corneal perforation may occur. Prolonged use may also produce severe keratitis.

Precautions: 

General:

Do not touch dropper tip to any surface as this may contaminate the solution. As with all anesthetics, continuous and prolonged use should be avoided. Protection of the eye from irritating chemicals, foreign bodies and rubbing during the period of anesthesia is very important. Tetracaine Hydrochloride Ophthalmic Solution, USP 0.5% should be used cautiously in patients with known allergy or cardiac disease. If signs of sensitivity develop during the treatment or irritation persists or increases, patients should be advised to discontinue use and consult prescribing physician.

Information for Patients:

Keep this and all drugs out of the reach of children. In case of accidental ingestion, seek professional assistance or contact a Poison Control Center immediately.

After instillation of this product, the surface of the eye is insensitive and can be scratched without your feeling it. Do not rub eye. Do not instill this product repeatedly because severe eye damage may occur.

Carcinogenesis, Mutagenesis, Impairment of Fertility:

No studies have been conducted in animals or in humans to evaluate the potential of these effects.

Pregnancy Category C:

Animal reproduction studies have not been performed with Tetracaine Hydrochloride. It is also not known whether Tetracaine Hydrochloride can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Tetracaine Hydrochloride Ophthalmic Solution, USP 0.5% should be given to pregnant women only if clearly needed.

Nursing Mothers:

It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Tetracaine Hydrochloride Ophthalmic Solution, USP 0.5% is administered to a nursing mother.

Pediatric Use:

Safety and effectiveness in children have not been established.

Adverse Reactions: 

Transient symptoms (signs) such as stinging, burning and conjunctival redness may occur. A rare, severe, immediate type allergic corneal reaction has been reported characterized by acute diffuse epithelial keratitis with filament formation and/or sloughing of large areas of necrotic epithelium, diffuse stromal edema, descemetitis and iritis.

To Report SUSPECTED ADVERSE REACTIONS, contact Altaire Pharmaceuticals, Inc., at 631-722-5988 or 1-800-258-2471, 9am - 5pm EST Monday Friday, or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Dosage And Administration: 

For Tonometry and Other Procedures of Short Duration:
Instill one or two drops just prior to evaluation.

For Minor Surgical Procedures such as Foreign Body or Suture Removal:
Instill one or two drops every five to ten minutes for one to three doses.

For Prolonged Anesthesia as in Cataract Extraction:
Instill one or two drops in the eye(s) every five to ten minutes for three to five doses.

How Supplied: 

Tetracaine Hydrochloride Ophthalmic Solution, USP 0.5% is supplied in a 15mL size.

Storage: 

Store at room temperature, 15 -30 C (59 -86 F).

Keep container tightly closed. Protect from light.

Rev. 01/2018
MG #17273

Manufactured by: [LOGO]

Altaire pharmaceuticals, Inc.

Aquebogue, NY 11931 USA

Principal Display Panel 

NDC 59390-181-13
ALTACAINE
Tetracaine Hydrochloride
Ophthalmic Solution
USP, 0.5% STERILE
Rx Only
15 mL

PRINCIPAL DISPLAY PANEL NDC 59390-181-13 ALTACAINE Tetracaine Hydrochloride Ophthalmic Solution USP, 0.5% STERILE Rx Only 15 mL

ALTACAINE
tetracaine hydrochloride solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:59390-181
Route of Administration OPHTHALMIC
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
TETRACAINE HYDROCHLORIDE (UNII: 5NF5D4OPCI) (TETRACAINE - UNII:0619F35CGV) TETRACAINE HYDROCHLORIDE 5 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
CHLOROBUTANOL (UNII: HM4YQM8WRC)
BORIC ACID (UNII: R57ZHV85D4)
EDETATE DISODIUM (UNII: 7FLD91C86K)
POTASSIUM CHLORIDE (UNII: 660YQ98I10)
WATER (UNII: 059QF0KO0R)
HYDROCHLORIC ACID (UNII: QTT17582CB)
SODIUM HYDROXIDE (UNII: 55X04QC32I)
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:59390-181-13 15 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product 02/01/2002
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
UNAPPROVED DRUG OTHER 02/01/2002
Labeler - Altaire Pharmaceuticals Inc. (786790378)

Revised: 1/2018 Altaire Pharmaceuticals Inc.



Your use of this website constitutes your agreement to the terms and conditions linked below:
Terms and Conditions | Resources
2017 © Copyright PharmacyHQ.com. Questions?
Please contact: pharmacyhq.mail@gmail.com